Dr. Reddy's launches generic LIPITOR tablets in the U.S.

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Jul 18 2012Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched ATORVASTATIN CALCIUM TABLETS 10 mg, 20 mg, 40 mg and 80 mg, a bioequivalent generic version of LIPITOR® (atorvastatin calcium) tablets, in the US market on July 17, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for atorvastatin calcium tablets.

The LIPITOR® brand had U.S. sales of approximately $8.07 billion for the most recent twelve months ending March 2012 according to IMS Health.

Dr. Reddy's Atorvastatin Calcium Tablets in 10 mg, 20 mg, 40 mg and 80 mg are available in bottle count sizes of 90 and 500.

Source:

Dr. Reddy's Laboratories

Posted in: Pharmaceutical News

Tags: , , , , ,

Comments (0)

Suggested Reading

The relationship between calcium consumption at various times of the day and cardiovascular disease
Cardiovascular risk can rise sharply after women go through menopause
Researchers identify a novel mechanism connected to the early stages of Alzheimer's disease
How minerals influence women's fertility and menstrual health
Link between nutrient intake and multimorbidity risk reported in recent study, more research is needed
Study reveals novel approach to promote efficient uptake of ASOs into cancer cells
Unlocking the molecular mysteries of autism and intellectual disability
Calcium crystal deposits linked to worsening knee osteoarthritis, study finds

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Coronary artery calcium scoring with CT can predict risk of heart attacks or strokes